This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Xrad Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Robert Goodnow
Introduction
Robert Goodnow is a notable inventor based in Concord, MA (US). He has made significant contributions to the field of oncology through his innovative research and development of pharmaceutical compounds. His work focuses on the treatment of oncologic diseases, showcasing his commitment to advancing medical science.
Latest Patents
Goodnow holds a patent for "Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy." This patent includes compounds of the Formula (I), (II), and (III), as well as pharmaceutically acceptable salts thereof. The compounds are designed to be effective in treating oncologic diseases, highlighting their potential in cancer therapy.
Career Highlights
Goodnow is currently associated with Xrad Therapeutics, Inc., where he continues to push the boundaries of cancer treatment. His work is characterized by a strong focus on developing innovative solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Goodnow collaborates with esteemed colleagues such as Jianmin Fu and Yaode Wang. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.
Conclusion
Robert Goodnow's contributions to the field of oncology through his patent and work at Xrad Therapeutics, Inc. exemplify the impact of dedicated inventors in advancing medical science. His innovative approach to cancer treatment continues to inspire progress in the fight against oncologic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile